Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


Hutchison China MediTech Limited (Chi-Med) (AIM/Nasdaq: HCM) today announces that Christian Hogg, Chief Executive Officer, will present at the 39th Annual JP Morgan Healthcare Conference taking place virtually on Monday January 11, 2021 at 8a.m. EST (1p.m. GMT / 9p.m. HKT).


GlobeNewswire Inc | Dec 22, 2020 02:00AM EST

December 22, 2020

HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., Dec. 22, 2020 (GLOBE NEWSWIRE) -- Hutchison China MediTech Limited (Chi-Med) (AIM/Nasdaq: HCM) today announces that Christian Hogg, Chief Executive Officer, will present at the 39th Annual JP Morgan Healthcare Conference taking place virtually on Monday January 11, 2021 at 8a.m. EST (1p.m. GMT / 9p.m. HKT).

The presentation will be webcast live and can be accessed at www.chi-med.com in the Shareholder Information section under Events, Circulars & Forms. Investors interested in listening to the live webcast should log on before the start time to download any software required. A replay of the event will be available shortly thereafter, for 90 days.

About Chi-Med

Chi-Med (Nasdaq/AIM: HCM) is an innovative, commercial-stage, biopharmaceutical company committed, over the past twenty years, to the discovery and global development of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. It has a portfolio of nine cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. For more information, please visit: www.chi-med.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements involve risks and uncertainties. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. For further discussion of these and other risks, see Chi-Meds filings with the U.S. Securities and Exchange Commission and on AIM. Chi-Med undertakes no obligation to update or revise the information contained in this press release, whether as a result of new information, future events or circumstances or otherwise.

CONTACTS

Investor Enquiries Mark Lee, Senior Vice President +85221218200Annie Cheng, Vice President +1(973)5673786 Media Enquiries Americas ? Brad Miles, Solebury +1(917)5707340(Mobile)Trout bmiles@troutgroup.comEurope ? Ben Atwell / Alex +442037271030 / +447771913902(Mobile) /Shaw, FTI Consulting +447779545055(Mobile) Chi-Med@fticonsulting.com +85298505033 (Mobile), jlo@brunswickgroup.comAsia ? Joseph Chi Lo / Zhou Yi, /Brunswick +85297836894(Mobile), y zhou@brunswickgroup.com Nominated Advisor Freddy Crossley / AthollTweedie, Panmure Gordon +44(20)78862500(UK)Limited







Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC